Works by Yerushalmi, Rinat

Results: 59
    1

    Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy.

    Published in:
    JNCI Cancer Spectrum, 2020, v. 4, n. 1, p. N.PAG, doi. 10.1093/jncics/pkz085
    By:
    • Rugo, Hope S;
    • Ettl, Johannes;
    • Hurvitz, Sara A;
    • Gonçalves, Anthony;
    • Lee, Kyung-Hun;
    • Fehrenbacher, Louis;
    • Mina, Lida A;
    • Diab, Sami;
    • Woodward, Natasha E;
    • Yerushalmi, Rinat;
    • Goodwin, Annabel;
    • Blum, Joanne L;
    • Martin, Miguel;
    • Quek, Ruben G W;
    • Tudor, Iulia Cristina;
    • Bhattacharyya, Helen;
    • Gauthier, Eric;
    • Litton, Jennifer K;
    • Eiermann, Wolfgang
    Publication type:
    Article
    2
    3
    4
    5
    6

    Perception of prognosis of cancer patients by non-oncologists.

    Published in:
    2016
    By:
    • Goldvaser, Hadar;
    • Milman, Yonatan;
    • Dujovni, Tal;
    • Stern, Anat;
    • Mahamid, Muhamad;
    • Hanovich, Ekaterina;
    • Zivony, Amir;
    • Shochat, Tzippy;
    • Yerushalmi, Rinat;
    • Gafter‐Gvili, Anat;
    • Brenner, Baruch;
    • Shepshelovich, Daniel
    Publication type:
    journal article
    7
    8

    A Dedicated Follow-Up Clinic for BRCA Mutation Carriers.

    Published in:
    Israel Medical Association Journal, 2016, v. 18, n. 9, p. 549
    By:
    • Yerushalmi, Rinat;
    • Rizel, Shulamith;
    • Zoref, Dalia;
    • Sharon, Eran;
    • Eitan, Ram;
    • Sabah, Gad;
    • Grubstein, Ahuva;
    • Rafson, Yael;
    • Cohen, Maya;
    • Magen, Ada;
    • Birenboim, Iehudit;
    • Margel, David;
    • Ozlavo, Rachel;
    • Sulkes, Aaron;
    • Brenner, Baruch;
    • Perry, Shlomit
    Publication type:
    Article
    9
    10

    Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00549-8
    By:
    • Rotem, Ofer;
    • Peretz, Idit;
    • Leviov, Michelle;
    • Kuchuk, Iryna;
    • Itay, Amit;
    • Tokar, Margarita;
    • Paluch-Shimon, Shani;
    • Maimon, Ofra;
    • Yerushalmi, Rinat;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Goldvaser, Hadar;
    • Samih, Yosef;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 210, n. 1, p. 167, doi. 10.1007/s10549-024-07549-7
    By:
    • Goldvaser, Hadar;
    • Yerushalmi, Rinat;
    • Mutai, Raz;
    • Kuchuk, Iryna;
    • Toker, Margarita;
    • Paluch-Shimon, Shani;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Sela, Gil Bar-;
    • Shai, Ayelet;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    26

    ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.

    Published in:
    Breast Cancer Research & Treatment, 2025, v. 209, n. 3, p. 167, doi. 10.1007/s10549-024-07549-7
    By:
    • Goldvaser, Hadar;
    • Yerushalmi, Rinat;
    • Mutai, Raz;
    • Kuchuk, Iryna;
    • Toker, Margarita;
    • Paluch-Shimon, Shani;
    • Drumea, Karen;
    • Evron, Ella;
    • Sonnenblick, Amir;
    • Gal-Yam, Einav;
    • Sela, Gil Bar-;
    • Shai, Ayelet;
    • Merose, Rotem;
    • Bareket-Samish, Avital;
    • Soussan-Gutman, Lior;
    • Stemmer, Salomon M.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37

    Second breast cancer: recurrence score results, clinicopathologic characteristics, adjuvant treatments, and outcomes—exploratory analysis of the Clalit registry.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00586-3
    By:
    • Shachar, Shlomit S.;
    • Leviov, Michelle;
    • Yerushalmi, Rinat;
    • Drumea, Karen;
    • Tokar, Margarita;
    • Soussan-Gutman, Lior;
    • Bareket-Samish, Avital;
    • Sonnenblick, Amir;
    • Ben-Baruch, Noa;
    • Evron, Ella;
    • Gal-Yam, Einav Nili;
    • Paluch-Shimon, Shani;
    • Bar-Sela, Gil;
    • Goldvaser, Hadar;
    • Stemmer, Salomon M.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 188, n. 2, p. 379, doi. 10.1007/s10549-021-06198-4
    By:
    • Reinhorn, Daniel;
    • Kuchuk, Iryna;
    • Shochat, Tzippy;
    • Nisenbaum, Bella;
    • Sulkes, Aaron;
    • Hendler, Daniel;
    • Rotem, Ofer;
    • Tsoref, Daliah;
    • Olitzky, Olga;
    • Goldvaser, Hadar;
    • Sarfaty, Michal;
    • Neiman, Victoria;
    • Prus, Judit;
    • Gottfried, Maya;
    • Yust-Katz, Shlomit;
    • Yerushalmi, Rinat
    Publication type:
    Article
    48
    49
    50